ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.7918
0.00%
Brent Oil
80.005
0.00%
Bitcoin
103,682.72
-0.41%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Emeis SA (EMEIS) Cotización

Emeis SA

Emeis SA (EMEIS)

EU
5.75
0.39
(7.28%)
Cerrado 17 Enero 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
5.75
Postura de Compra
5.562
Postura de Venta
5.75
Volume Operado de la Acción
361,603
5.39 Rango del Día 5.75
4.44 Rango de 52 semanas 13.60
Capitalización de Mercado [m]
371.559k
Precio Anterior
5.36
Precio de Apertura
5.39
Hora
56
@
5.75
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
394,351
Acciones en circulación
64,619
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
20.97k
turnover
5.39B
Beneficio neto
1.35B

Acerca de Emeis SA

Sector
Health & Allied Services,nec
Industria
Health & Allied Services,nec
Sitio web
www.emeis-group.com
Sede
Puteaux, Hauts-de-seine, Fra
Fundado
-
Emeis SA is listed in the Health & Allied Services sector of the Euronext with ticker EMEIS. The last closing price for Emeis was 5.36 €. Over the last year, Emeis shares have traded in a share price range of 4.44 € to 13.60 €.

Emeis currently has 64,619 shares in issue. The market capitalisation of Emeis is 346,357.84 € . Emeis has a price to earnings ratio (PE ratio) of 0.00.

EMEIS Últimas noticias

Más noticias

emeis: Half-Year Review (H2 2024) of the Liquidity Agreement Entered Into With Natixis Oddo BHF

Regulatory News: Under the liquidity agreement entrusted by emeis (the “Company”) (Paris:EMEIS) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as of...

14 Enero 2025
Business Wire

Information relative au nombre total de droits de vote et d’actions composant le capital social de la société emeis

Articles L.233-8-II du Code de commerce et 223-16 du Règlement Général de l’Autorité des marchés financiers Regulatory News: emeis (Paris:EMEIS) : Déclaration au 31 décembre 2024 Nombre de titres...

09 Enero 2025
Business Wire

emeis annonce 251 M€ de cessions opérationnelles et immobilières depuis début octobre

Portant à près de 900 M€ le volume de cessions réalisées depuis mi 2022 ou sécurisées à date Cession des activités Chilienne et en République Tchèque Regulatory News: emeis (Paris:EMEIS) annonce...

18 Diciembre 2024
Business Wire

Information relative au nombre total de droits de vote et d’actions composant le capital social de la société emeis

Articles L.233-8-II du Code de commerce et 223-16 du Règlement Général de l’Autorité des marchés financiers Regulatory News: emeis (Paris:EMEIS) : Déclaration au 30 novembre 2024 Nombre de titres...

05 Diciembre 2024
Business Wire

Information relative au nombre total de droits de vote et d’actions Composant le capital social de la société emeis

Articles L.233-8-II du Code de commerce et 223-16 du Règlement Général de l’Autorité des marchés financiers Regulatory News: emeis (Paris:EMEIS) : Déclaration au 31 octobre 2024 Nombre de...

06 Noviembre 2024
Business Wire

emeis: Upturn in Performance Confirmed in Third-Quarter 2024

Revenue up +8.3%, occupancy rate up +2.6 points Regulatory News: emeis (Paris:EMEIS): Growth in all core activities and in all geographical areas (revenue and occupancy rate) Solid growth of...

29 Octubre 2024
Business Wire

emeis: Availability of the 2024 Half-Year Financial Report

Regulatory News: emeis (Paris:EMEIS) filed, today, its half-year financial report for the period starting on 1 January 2024 and ending on 30 June 2024, with the French Autorité des Marchés...

10 Octubre 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.4418.306649086465.3095.755.211670445.33929498DE
40.9920.79831932774.766.6094.61053567635.70884398DE
120.6612.96660117885.097.064.443943515.70342441DE
26-6.752-54.007358822612.50213.64.443686156.93657448DE
52-6.53-53.175895765512.2813.64.443563287.2140011DE
156-6.53-53.175895765512.2813.64.443563287.2140011DE
260-6.53-53.175895765512.2813.64.443563287.2140011DE

EMEIS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Emeis?
El precio actual de las acciones de Emeis es 5.75 €
¿Cuántas acciones de Emeis están en circulación?
Emeis tiene 64,619 acciones en circulación
¿Cuál es la capitalización de mercado de Emeis?
La capitalización de mercado de Emeis es EUR 346.36k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Emeis?
Emeis ha negociado en un rango de 4.44 € a 13.60 € durante el último año
¿Cuál es el ratio de efectivo a ventas de Emeis?
El ratio de efectivo a ventas de Emeis es 0
¿Cuál es la moneda de reporte de Emeis?
Emeis presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Emeis?
El último ingresos anual de Emeis es EUR 5.39B
¿Cuál es el último beneficio anual de Emeis?
El último beneficio anual de Emeis es EUR 1.35B
¿Cuál es la dirección registrada de Emeis?
La dirección registrada de Emeis es 12 , RUE JEAN JAURES, CS 10032, PUTEAUX, HAUTS-DE-SEINE, 92813
¿Cuál es la dirección del sitio web de Emeis?
La dirección del sitio web de Emeis es www.emeis-group.com
¿En qué sector industrial opera Emeis?
Emeis opera en el sector HEALTH & ALLIED SERVICES,NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DRVDSDrone Volt
0.0039 €
(3,800.00%)
774.48k
GTRDSGroupe Tera DS
0.0585 €
(800.00%)
3.27k
ALCYBCybergun
0.0002 €
(100.00%)
3.98M
DMSBSDiagnostic Medical Systems
0.0075 €
(87.50%)
129.59k
NICBSNicox SA
0.0265 €
(50.57%)
979
MLSMLSmalto
0.014 €
(-33.33%)
1.62k
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
MLIDSIds
0.364 €
(-19.11%)
1.12k
MCPGrupo Media Capital Sgps Sa
1.62 €
(-19.00%)
3
ALBOOBOOSTHEAT
0.063 €
(-15.78%)
70.91k
ATOAtos SE
0.002 €
(-4.76%)
2.53B
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
BCPBanco Comercial Portugues SA
0.4988 €
(0.79%)
69.25M
EDPEDP SA
3.149 €
(1.22%)
13.56M
VIVVivendi SE
2.546 €
(-1.01%)
8.93M

Discusión

Ver feed completo
AlwaysOptimistic AlwaysOptimistic 2 minutos hace
I also think there room and enough investors dollars out there for all things tech. Good chance there will be more foreign investment coming in with the change in admins for a more business friendly environment for foreign investment dollars.

JMO. Please do your own due diligence and
IONQ
Dodger1 Dodger1 3 minutos hace
https:/ /www.juliawalck.com/shop/p/the-most-important-meal-art-print
AABB
Dodger1 Dodger1 8 minutos hace
https ://www.juliawalck.com/shop/p/egg-on-your-face-art-print

$AABB
AABB
TightCoil TightCoil 8 minutos hace
We have to be wary of a Release with Conditions -
We must Fight, Fight, Fight For, INSIST ON:

UNCONDITIONAL RELEASE
FNMA
santafe2 santafe2 8 minutos hace
While all the focus is on tech criminals the real problem may be the crypto Ponzi scheme. They spent reportedly $170MM to get him elected. There's a reason he loves the poorly educated. This is the message heard loud and clear by everyone from banking to investment and, of course, every criminal in
quester614 quester614 12 minutos hace
MovyChem was a SCAM company along with Xeriant SRO. MovyChem EU is gone . No website for either. A company that took 20 years to develop Retacell just disappears. I have shown before that Xeriant SRO & MovyChem were started by Vladimír Bíža who can be tracked back to Aegea Inc/ Futureland SCAM He al
XERI
3331 3331 13 minutos hace
BIEL: HUGE HIT IN TAIWAN!
https://www.actipatchtw.com/general-1
dinogreeves dinogreeves 15 minutos hace
Once they kill all the options by the dead line, this will run. Market makers are begging for mercy they don't report before the deadline, they have probably colluded with the insiders too, it is plausible. The quote below is from someone on Stocktwits. Essentially I am not to only one with commo
SMCI
Werbe Werbe 18 minutos hace
Everyone that posts here start with some extraordinary story of upbringing or some sort of passive social shout.  Anyone a high-school dropout or start from welfare?  
CrypticDomain141 CrypticDomain141 21 minutos hace
I’ve done my research and I’m long.

I don’t understand why everyone is so shocked that this is still volatile at this time. It doesn’t have any revenue yet, and it doesn’t have a big pharm partner….yet.

But from the clinical trials it seems they’ve got the goods. The C
AVXL
Drugdoctor Drugdoctor 24 minutos hace
Here is our CEO's stock chart pattern... Soon we will see $SRNW sporting the same pattern.

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
SRNW
AlwaysOptimistic AlwaysOptimistic 24 minutos hace
I also saw that. Of course Chambers would take that position. He has a lot of capital invested in AI and other tech with his venture funding group (JC2 Ventures) and a lot to lose if investors siphon money away from AI in to quantum. Just like NVDIA. This too shall pass IMO.
IONQ
SSKILLZ1 SSKILLZ1 24 minutos hace
Why Pete would play there now is beyond me. Maybe he has a love of public humiliation?

I have no clue why either. At this point. Which is why I would be shocked if he comes back at this point.

One thing for sure: any Mets solution at first base that includes regularly p
4u2nv2 4u2nv2 24 minutos hace
I have looked at a lot of charts on IFUS. 1M, 1Y, 5Y and I specifically focused on the volume and PPS movement. I did say recently that I am not trading this stock. I do not own any or plan on buying it. I am more focused on a private business model than trading OTC or any stocks. But the IFUS PPS h
IFUS
nowwhat2 nowwhat2 24 minutos hace
Charts are just totally freaking SCREAMING that it COULD be a "Sell The News" Event......and yet ?

It's like.....



https://investorshub.advfn.com/uimage/uploads/2025/1/17/zvqmlxrp_!_17_hyper_845pm_CALVIN_INAUG_PARADE_ATH.jpg



XRPUSD
littlejohn littlejohn 25 minutos hace
SMCI will be at 47 to 48 in a Pop

before we can read the 10K

filing header...

That is why you gotta be ready before

it is filed...

Around $48 is the recent trading high

that market makers marked that may
SMCI
Drugdoctor Drugdoctor 26 minutos hace
Remember, assets from other stock mergers will be added to $FORW's holding company. Right now, something is happening with American Blockchain ($GVSI), our CEO's other shell, and if it is the first to merger, some assets will be coming here. Can't wait for $FORW's chart to look like this.
FORW
MONTANAJOE MONTANAJOE 27 minutos hace
Just amuse each other with their nonsense!
NBRI
TucsonPhil TucsonPhil 27 minutos hace
Wow. According to OTC markets, the OS count is now 5,988,649,454. Last time I checked was last year, and I recall it was around 3.9B, when the AS was 5B, then they raised the AS to 10B and have been busy with quite a bit of dilution.
KGKG
MONTANAJOE MONTANAJOE 27 minutos hace
Like it better when they just talk to each other and leave everyone else alone!!
NBRI
againstallodds againstallodds 29 minutos hace
https://investorshub.advfn.com/uimage/uploads/2025/1/17/rarvyIMG_0265.jpeg

0.5 oz of rhodium per ton of ore can be considered a very high-grade deposit. Here's why:
* Rhodium is extremely rare: It's one of the rarest and most valuable precious metals.
* Typical grades
NBRI
EarningsCentral EarningsCentral 31 minutos hace
TLRY
Drugdoctor Drugdoctor 32 minutos hace
Who made 300% gains-with-George-Sharp's-$GVSI??>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
axelvento axelvento 33 minutos hace
Moderna is preparing to advance mRNA-1018 into Phase 3. The Company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.
MRNA
gitreal gitreal 34 minutos hace
Could it be Mt Vernon assays are flawed, and that the extraordibary Rhodiun assays are skewed ?

Skewed? No.
Made up? Yes.
NBRI

Su Consulta Reciente

EU
EMEIS
Emeis
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados